Have a personal or library account? Click to login
Identification and expression of microRNA-34a-3p and its target Rapamycin-insensitive companion of mTOR (RICTOR) in polycystic ovarian syndrome in South Indian population Cover

Identification and expression of microRNA-34a-3p and its target Rapamycin-insensitive companion of mTOR (RICTOR) in polycystic ovarian syndrome in South Indian population

Acta Marisiensis - Seria Medica
Volume 70 (2024): Issue 3 (September 2024)
By: Manya Saravanan,  Ameya K P,  Ashikha Shirin Usman P P and  Durairaj Sekar  
Open Access
|Oct 2024

Authors

Manya Saravanan

Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai, India

Ameya K P

RNA Biology Lab, Saveetha Dental College and Hospital, Saveetha Institute of Medical And Technical Science (SIMATS), Saveetha University, Chennai, India

Ashikha Shirin Usman P P

RNA Biology Lab, Saveetha Dental College and Hospital, Saveetha Institute of Medical And Technical Science (SIMATS), Saveetha University, Chennai, India

Durairaj Sekar

duraimku@gmail.com

RNA Biology Lab, Saveetha Dental College and Hospital, Saveetha Institute of Medical And Technical Science (SIMATS), Saveetha University, Chennai, India
DOI: https://doi.org/10.2478/amma-2024-0025 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 163 - 168
Submitted on: Jan 11, 2024
Accepted on: Jul 30, 2024
Published on: Oct 2, 2024
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
polycystic ovary syndrome,
microRNA-34a-3p,
RICTOR,
gene expression,
diagnosis
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2024 Manya Saravanan, Ameya K P, Ashikha Shirin Usman P P, Durairaj Sekar, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 70 (2024): Issue 3 (September 2024)Next article